
Exploring the link between light exposure and longevity, researchers have uncovered compelling evidence that the amount and timing of light we experience daily can significantly influence our health. Individuals exposed to more daylight showed a decreased risk of death, suggesting that natural light plays a crucial role in sustaining our biological rhythms and overall health. Conversely, higher exposure to artificial light at night was associated with increased mortality risks, emphasizing the importance of darkness in maintaining our circadian health.
The study utilized data from over 88,000 participants who were monitored for their light exposure through wearable sensors, analyzing how variations in light affected their circadian rhythms—our body's natural clock regulating sleep and wake cycles. Those with a disrupted circadian rhythm, characterized by irregular light patterns, had higher risks of death, particularly from cardiometabolic diseases such as heart disease and diabetes. This suggests that maintaining a regular pattern of light and dark could be a preventative strategy against serious health issues.
The implications of this research are profound, advocating for the design of environments that enhance natural light exposure during the day and minimize light pollution at night. Such changes could potentially extend life expectancy and improve health, making a strong case for urban and workplace designs that consider circadian health impacts.
Article Information
Published in Proc Natl Acad Sci U S A. Daniel P. Windred et al.
Light enhances or disrupts circadian rhythms, depending on the timing of exposure. Circadian disruption contributes to poor health outcomes that increase mortality risk. Whether personal light exposure predicts mortality risk has not been established. We therefore investigated whether personal day and night light, and light patterns that disrupt circadian rhythms, predicted mortality risk. UK Biobank participants (N = 88,905, 62.4 ± 7.8 y, 57% female) wore light sensors for 1 wk. Day and night light exposures were defined by factor analysis of 24-h light profiles. A computational model of the human circadian pacemaker was applied to model circadian amplitude and phase from light data. Cause-specific mortality was recorded in 3,750 participants across a mean (±SD) follow-up period of 8.0 ± 1.0 y. Individuals with brighter day light had incrementally lower all-cause mortality risk (adjusted-HR ranges: 0.84 to 0.90 [50 to 70th light exposure percentiles], 0.74 to 0.84 [70 to 90th], and 0.66 to 0.83 [90 to 100th]), and those with brighter night light had incrementally higher all-cause mortality risk (aHR ranges: 1.15 to 1.18 [70 to 90th], and 1.21 to 1.34 [90 to 100th]), compared to individuals in darker environments (0 to 50th percentiles). Individuals with lower circadian amplitude (aHR range: 0.90 to 0.96 per SD), earlier circadian phase (aHR range: 1.16 to 1.30), or later circadian phase (aHR range: 1.13 to 1.20) had higher all-cause mortality risks. Day light, night light, and circadian amplitude predicted cardiometabolic mortality, with larger hazard ratios than for mortality by other causes. Findings were robust to adjustment for age, sex, ethnicity, photoperiod, and sociodemographic and lifestyle factors. Minimizing night light, maximizing day light, and keeping regular light-dark patterns that enhance circadian rhythms may promote cardiometabolic health and longevity.